ACS Chemical Neuroscience Spotlight on CEP-1347

被引：13
|
作者：
Sweeney, Zachary K. [1 ]
Lewcock, Joseph W. [2 ]
机构：
[1] Genentech Inc, Dept Small Mol Drug Discovery, San Francisco, CA 94080 USA
[2] Genentech Inc, Dept Neurobiol, San Francisco, CA 94080 USA
来源：
ACS CHEMICAL NEUROSCIENCE | 2011年 / 2卷 / 01期
关键词：
KINASE INHIBITOR CEP-1347; PARKINSONS-DISEASE; NEURONS; PATHWAY; KT7515;
D O I：
10.1021/cn1000793
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：3 / 4
页数：2
相关论文
共 50 条
  • [31] ACS Chemical Neuroscience Molecule Spotlight on Begacestat (GSI-953)
    Hopkins, Corey R.
    ACS CHEMICAL NEUROSCIENCE, 2012, 3 (01): : 3 - 4
  • [32] ACS Chemical Neuroscience Molecule Spotlight on STX209 (Arbaclofen)
    Hopkins, Corey R.
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (08): : 381 - 381
  • [33] ACS Chemical Neuroscience Molecule Spotlight on Semagacestat (LY450139)
    Hopkins, Corey R.
    ACS CHEMICAL NEUROSCIENCE, 2010, 1 (08): : 533 - 534
  • [34] Comparison of the pharmacokinetics and metabolism of CEP-1347 between Sprague Dawley and Wistar Han rats
    Ring, SC
    Yu, EY
    Chovan, JP
    DRUG METABOLISM REVIEWS, 2003, 35 : 49 - 49
  • [35] CEP-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family
    Maroney, AC
    Finn, JP
    Connors, TJ
    Durkin, JT
    Angeles, T
    Gessner, G
    Xu, ZH
    Meyer, SL
    Savage, MJ
    Greene, LA
    Scott, RW
    Vaught, JL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (27) : 25302 - 25308
  • [36] ACS Chemical Neuroscience Molecule Spotlight on Gilenya (Fingolimod; FTY720)
    Hopkins, Corey R.
    ACS CHEMICAL NEUROSCIENCE, 2011, 2 (03): : 116 - 117
  • [37] Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway
    Maroney, AC
    Glicksman, MA
    Basma, AN
    Walton, KM
    Knight, E
    Murphy, CA
    Bartlett, BA
    Finn, JP
    Angeles, T
    Matsuda, Y
    Neff, NT
    Dionne, CA
    JOURNAL OF NEUROSCIENCE, 1998, 18 (01): : 104 - 111
  • [38] Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
    Wang, Leo H.
    Johnson, Eugene M., Jr.
    NEUROLOGY, 2008, 71 (06) : 462 - 462
  • [39] Mixed lineage kinase inhibitor CEP-1347 fails to delay disability in early Parkinson disease
    Shoulson, Ira
    Schwid, Steven
    Hyson, Christopher
    Oakes, David
    Gorbold, Emily
    Rudolph, Alice
    Shinaman, Aileen
    Kamp, Cornelia
    Kieburtz, Karl
    Lang, Anthony
    Fahn, Stanley
    Gauger, Lisa
    Goetz, Christopher
    Marek, Kenneth
    Seibyl, John
    NEUROLOGY, 2007, 69 (15) : 1480 - 1490
  • [40] Repositioning CEP-1347, a chemical agent originally developed for the treatment of Parkinson's disease, as an anti-cancer stem cell drug
    Okada, Masashi
    Takeda, Hiroyuki
    Sakaki, Hirotsugu
    Kuramoto, Kenta
    Suzuki, Shuhei
    Sanomachi, Tomomi
    Togashi, Keita
    Seino, Shizuka
    Kitanaka, Chifumi
    ONCOTARGET, 2017, 8 (55) : 94872 - 94882
12345